Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.4.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.4.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.4.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.4.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.7.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.7.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.7.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used